Barclays
EHC icon

Barclays’s Encompass Health EHC Stock Holding History

Barclays’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-31,174
Closed -$1.59M – 5720
2020
Q1 		$1.59M Sell
31,174
-14,078
-31% -$812K ﹤0.01% 2498
2019
Q4 		$2.49M Buy
45,252
+44,498
+5,902% +$2.41M ﹤0.01% 2769
2019
Q3 		$38K Buy
754
+377
+100% +$18.9K ﹤0.01% 6014
2019
Q2 		$19K Sell
377
-18,855
-98% -$915K ﹤0.01% 6420
2019
Q1 		$894K Buy
19,232
+19,106
+15,163% +$968K ﹤0.01% 3523
2018
Q4 		$6K Hold
126
– – ﹤0.01% 6369
2018
Q3 		$8K Buy
+126
New +$7.66K ﹤0.01% 6703
2017
Q4 		– Sell
-126
Closed -$5K – 6961
2017
Q3 		$5K Sell
126
-1,257
-91% -$44.8K ﹤0.01% 6403
2017
Q2 		$53K Buy
1,383
+1,257
+998% +$46K ﹤0.01% 5324
2017
Q1 		$4K Sell
126
-5,908
-98% -$194K ﹤0.01% 6321
2016
Q4 		$198K Buy
6,034
+4,903
+434% +$159K ﹤0.01% 4220
2016
Q3 		$37K Buy
1,131
+880
+351% +$28.5K ﹤0.01% 5151
2016
Q2 		$8K Hold
251
– – ﹤0.01% 5610
2016
Q1 		$7K Sell
251
-378
-60% -$10.4K ﹤0.01% 5569
2015
Q4 		$17K Sell
629
-1,131
-64% -$32.2K ﹤0.01% 5240
2015
Q3 		$53K Sell
1,760
-11,941
-87% -$416K ﹤0.01% 4989
2015
Q2 		$501K Buy
+13,701
New +$489K ﹤0.01% 3475
2015
Q1 		– Sell
-1,131
Closed -$34K – 7116
2014
Q4 		$34K Sell
1,131
-629
-36% -$19.6K ﹤0.01% 5988
2014
Q3 		$50K Buy
1,760
+1,006
+133% +$30.7K ﹤0.01% 5878
2014
Q2 		$21K Sell
754
-1,006
-57% -$28K ﹤0.01% 6479
2014
Q1 		$49K Sell
1,760
-7,039
-80% -$183K ﹤0.01% 6010
2013
Q4 		$231K Buy
8,799
+7,542
+600% +$210K ﹤0.01% 4865
2013
Q3 		$34K Sell
1,257
-7,291
-85% -$187K ﹤0.01% 6268
2013
Q2 		$196K Buy
+8,548
New +$193K ﹤0.01% 5198

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Barclays's EHC Position: Q2 2026 in Review

Barclays reduced its Encompass Health (EHC) stake by 39% in Q2 2026, selling an estimated $13.1M and leaving 201,858 shares worth $20.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1122.

Barclays first reported a position in EHC in Q2 2013 and has held it in 53 quarters since. The position peaked at $31.8M in Q1 2026. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Barclays held 201,858 shares of Encompass Health worth $20.4M as of Q2 2026.
  • Barclays sold 126,689 Encompass Health shares in Q2 2026, an estimated $13.1M.
  • Encompass Health made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1122 holding.
  • Barclays first reported a position in Encompass Health in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Encompass Health position peaked at $31.8M in Q1 2026.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.